Cardiovascular Device Update articles from October 2007

Cardiovascular Device Update archives from October 2007

WAR ! vs. heart failure.
October 1, 2007... WAR ! vs. heart failure But best weaponry lacking to win the big battles By DON LONG, Cardiovascular Device Update Executive Editor, And MARK McCARTY, Cardiovascular Device Update Washington Editor WASHINGTON u Healthcare in...

As to the NHLBI 'roadmap' ... Critic charges NIH grant protocols drive out innovative research.
October 1, 2007... As to the NHLBI 'roadmap'... ... Critic charges NIH grant protocols drive out innovative research WASHINGTON -- In an opening plenary session at this year's conference of the Heart Failure Society of America (St. Paul, Minnesota),...

Thoratec exhibit features real-life case studies.(Brief article)
October 1, 2007... Thoratec exhibit features real-life case studies Poised to be one of the latest generation ventricular assist devices (VADs) to win FDA approval is the HeartMate II from Thoratec (Pleasanton, California). The company featured the...

Europe developing advanced systems for heart failure.
October 1, 2007... Europe developing advanced systems for heart failure By MICHAEL SIMONSEN, PhD, CDU Contributing Editor VIENNA u Cardiovascular disease remains the No. 1 cause of death in Europe, making the market for products used in diagnosing,...

DES use: waiting for 2.0 resorbable?(Clinical report)
October 1, 2007... DES use: waiting for 2.0 resorbable? As a result of safety issues with DES u recently reinforced by the COURAGE study, and others, indicating that PCI/stenting may offer no greater length of life than medical therapy u utilization has...

Conference tackles PAD pandemic fueled by diabetes, aging.(Conference news)
October 1, 2007... Conference tackles PAD pandemic fueled by diabetes, aging By LARRY HAIMOVITCH, CDU Contributing Writer The fifth annual Vascular Interventional Advances (VIVA) meeting took place in Las Vegas in late September, with that gathering...

FDA panel votes down flexibility in trials for AF catheter ablation.
October 1, 2007... FDA panel votes down flexibility in trials for AF catheter ablation By MARK McCARTY, CDU Washington Editor How do you do a randomized controlled trial (RCT) when the product you are testing seems to be such a great potential advancement...

Pharma developments.
October 1, 2007... Pharma developments AHRQ, FDA will examine ADHD drug cardiac risks Editor's note: While Cardiovascular Device Update is obviously directed toward manufacturers of medical devices and organizations in the med-tech sector, also of...

International report.
October 1, 2007... International report Left main artery disease found in inherited clusters German researchers have found that heart disease of the left main coronary artery is often an inherited condition that clusters in families. Moreover, they...

Acquisitions/Deals.
October 1, 2007... Acquisitions/Deals * Advanced Cell Technology (ACT; Alameda, California) completed its previously disclosed acquisition of the outstanding capital stock of Mytogen (Charlestown, Massachusetts). At the end of May, ACT agreed to acquire...

Business developments.
October 1, 2007... Business developments 'Less safe' argument fails to win patent ruling for J&J/Cordis By HOLLAND JOHNSON, CDU Managing Editor Your patent counsel comes to you and tells you that the best way to fight off a patent infringement claim...

Agreements.
October 1, 2007... Agreements * Cardica (Redwood, City, California) and Cook Medical (Bloomington, Indiana) reported expansion of an agreement regarding the development of vascular closure devices first disclosed in June. Cook will pay Cardica up to...

Market & technology updates.
October 1, 2007... Market & technology updates New study finds comparable risks for DES and BMS By AMANDA PEDERSEN, CDU Staff Writer, and DON LONG, CDU Executive Editor A new meta-analysis published last month in The Lancet is being touted as easing...

Personnel file.(BSP Medical )(Cardio3 BioSciences)(Haemonetics)
October 1, 2007... Personnel file * Linda Davrath has been named head of clinical research and clinical application for BSP Medical (Tel Aviv, Israel). Amir Beker, BSP's CEO, said "Dr. Davrath has vast and valuable experience in the field of cardiopulmonary...

Product pipeline.
October 1, 2007... Product pipeline Spectranetics PATENT study explores plaque removal above knee By OMAR FORD, CDU Staff Writer In-stent restenosis is a major issue when it comes to percutaneous coronary intervention of coronary vessels, often...

At press time ...
October 1, 2007... At press time... Luna in alliance with Terumo Cardiovascular A CDU Staff Report Luna Innovations (Roanoke, Virginia) reported that it has entered a joint marketing alliance with Terumo Cardiovascular Systems (Terumo CVS). Luna...